Securities code: Honz Pharmaceutical Co.Ltd(300086) securities abbreviation: Honz Pharmaceutical Co.Ltd(300086) Announcement No.: 2022024
Honz Pharmaceutical Co.Ltd(300086)
Announcement of resolutions of the 18th meeting of the 5th board of supervisors
The company and all members of the board of supervisors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Honz Pharmaceutical Co.Ltd(300086) (hereinafter referred to as " Honz Pharmaceutical Co.Ltd(300086) " or "the company") the 18th meeting of the 5th board of supervisors was held on April 6, 2022 in the conference room of the company, No. 6, Yaogu Third Road, Yaogu Industrial Park, Haikou national high tech Industrial Development Zone. The notice of the meeting was sent on March 28, 2022 by mail, telephone and in writing. Three supervisors should attend the meeting and three supervisors actually attended the meeting, which is in line with the provisions of the company law of the people's Republic of China, the articles of association and other laws and regulations. The meeting was presided over by Mr. Gao Hongchang, chairman of the board of supervisors of the company. After careful deliberation, all the supervisors present at the meeting passed the following proposals:
1. The 2021 work report of the board of supervisors of the company was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
During the reporting period, all members of the board of supervisors, in accordance with the company law of the people's Republic of China, the articles of association, the rules of procedure of the board of supervisors and other relevant provisions, honestly and diligently performed the duties entrusted by the articles of association, safeguarded the interests of the company and shareholders, held 9 meetings, participated in 1 general meeting of shareholders and attended 10 meetings of the board of directors as nonvoting delegates.
The members of the board of supervisors of the company earnestly performed their duties, actively carried out their work, attended all previous board meetings as nonvoting delegates, and conducted a series of supervision and audit activities on the standardized operation, financial status, foreign investment and use of funds of the company.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
For details, please refer to the company's publication on cninfo (www.cn. Info. Com. CN.) on the same day And the work report of the board of supervisors in 2021 on the information disclosure website designated by the CSRC.
2. The annual report and summary for 2021 was considered and adopted by 3 votes in favor, 0 against and 0 abstention. After review, the board of supervisors believes that the 2021 annual report and summary prepared and reviewed by the board of directors comply with laws, regulations, the provisions of the CSRC and Shenzhen Stock Exchange, and the content of the report is true, accurate and completely reflects the actual situation of the company's operation in 2021, without any false records, misleading statements or major omissions.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
For details, please refer to the company's publication on cninfo (www.cn. Info. Com. CN.) on the same day And the 2021 annual report and its abstract on the information disclosure website designated by the CSRC.
3. The 2021 annual financial statement of the company was reviewed and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
This proposal still needs to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation.
For details, please refer to the company's publication on cninfo (www.cn. Info. Com. CN.) on the same day And the company's 2021 financial statement on the information disclosure website designated by the CSRC.
4. The 2021 profit distribution plan of the company was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
After review, the board of supervisors believes that the 2021 profit distribution plan proposed by the board of directors is in line with the current actual operation of the company, conducive to the sustainable and stable development of the company, and there is no damage to the interests of the company and all shareholders. Agree to submit the proposal to the general meeting of shareholders of the company for deliberation.
5. The special report on the deposit and use of the company's raised funds in 2021 was reviewed and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
After review, the board of supervisors believes that the special report on the deposit and use of raised funds in 2021 prepared by the board of directors truly, accurately and completely reflects the company's matters on the deposit and use of raised funds in 2021. The board of directors and senior managers of the company have performed legal procedures in strict accordance with the requirements of relevant laws, administrative regulations, normative documents and relevant systems of the company, And timely disclosed the details to the majority of investors, without false records, misleading statements or major omissions.
For details, please refer to the company's publication on cninfo (www.cn. Info. Com. CN.) on the same day And the special report on the deposit and use of the company's raised funds in 2021 on the information disclosure website designated by the CSRC. 6. The 2021 internal control self-evaluation report was reviewed and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
After review, the board of supervisors believes that the company has established a relatively perfect internal control system, which meets the requirements of relevant national laws and regulations and the actual needs of the company's production and operation management, and can be effectively implemented. The establishment of the internal control system has played a good role in risk prevention and control of all links of the company's production and operation management. The company's self-evaluation report on internal control in 2021 truly and objectively reflects the construction and operation of the company's internal control system.
For details, please refer to cninfo.com.cn And other relevant announcements on the information disclosure website designated by the CSRC, such as the 2021 internal control self-evaluation report and relevant opinion announcement, and the 2021 internal control audit report.
7. The proposal on daily connected transactions in 2022 was considered and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
After deliberation, all supervisors agreed that:
The related party transactions between the company and related parties are necessary for the normal operation and management of the company. The transaction price is determined according to the fair and reasonable pricing policy and with reference to the market price, which will not damage the interests of the company and the majority of small and medium-sized investors and affect the independence of the company.
For details, please refer to the company's publication on cninfo (www.cn. Info. Com. CN.) on the same day And the proposal on the expected daily connected transactions in 2022 on the information disclosure website designated by the CSRC.
8. The proposal on comprehensive credit line was reviewed and approved by financial institutions with 0 affirmative votes and 0 abstention votes.
After review, the board of supervisors believes that the relevant matters of the proposal are for the daily working capital turnover of the company and its wholly-owned subsidiaries, holding subsidiaries and holding subsidiaries, which is conducive to reducing the company's financial expenses, is in line with the company's overall development strategy, will not damage the interests of the company and minority shareholders, and the relevant approval procedures comply with the relevant provisions of laws and regulations and the articles of association. Therefore, we unanimously agree with the proposal.
For details, please refer to cninfo.com.cn And the announcement on matters related to applying for comprehensive credit line from financial institutions on the information disclosure website designated by the CSRC. It is hereby announced.
Honz Pharmaceutical Co.Ltd(300086)
Board of supervisors
April 6, 2022
